# Zenas BioPharma, Inc.: Form SCHEDULE 13D/A, filed Oct 14, 2025

- Company: [Zenas BioPharma, Inc.](/companies/zbio.md) (CIK 1953926)
- Form: SCHEDULE 13D/A
- Filed: 2025-10-14
- Accepted by EDGAR: Oct 14, 2025, 17:29 ET
- Period: not reported
- Accession: 0001193125-25-239173
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1953926/000119312525239173/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1953926/000119312525239173/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1953926/000119312525239173/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Oct 14, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-239173. Last ingested by Listed: Nov 6, 2026, 16:59 ET. No prices; not investment advice.